Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1093/brain/awx108 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Interleukin-2-based therapies in cancer.
Sci Transl Med
November 2022
Department of Immunology, University Hospital Zurich, Zurich, Switzerland.
Molecular insights into the mechanism of beneficial and adverse effects of interleukin-2 (IL-2) have resulted in the development of improved IL-2 formulations with IL-2 receptor bias and tissue-targeting properties. Several of these compounds are currently in clinical development and are ushering IL-2 therapy into the current era of cancer immunotherapy.
View Article and Find Full Text PDFBeneficial effect of interleukin-2-based immunomodulation in Alzheimer-like pathology.
Brain
July 2017
INSERM, UMRS 938, CdR Saint-Antoine, Laboratory Immune System, Neuroinflammation and Neurodegenerative Diseases, Hôpital Saint-Antoine, F-75012, Paris, France.
Reply: Beneficial effect of interleukin-2-based immunomodulation in Alzheimer-like pathology.
Brain
July 2017
INSERM U1169/MIRCen CEA 92265 Fontenay aux Roses and Université Paris-Sud, Université Paris Saclay, 91400 Orsay, France.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!